PD-L1 expression and survival in patients with locally advanced cervical cancer treated with chemoradiotherapy

被引：0
|
作者：
Enwere, E. [1 ]
Kornaga, E. [2 ]
Koulis, T. [3 ]
Dean, M. [2 ]
Phan, T. [3 ]
Ghatage, P. [4 ]
Magliocco, A. [5 ]
Lees-Miller, S. [6 ]
Doll, C. [3 ]
机构：
[1] Tom Baker Canc Clin, Pathol & Lab Med, Translat Lab, Funct Tissue Imaging Unit, Calgary, AB, Canada
[2] Tom Baker Canc Clin, Pathol & Lab Med, Translat Lab, Calgary, AB, Canada
[3] Univ Calgary, Oncol, Calgary, AB, Canada
[4] Univ Calgary, Gynecol Oncol, Calgary, AB, Canada
[5] Univ S Florida, H Lee Moffitt Canc Ctr, Anat Pathol, Tampa, FL 33682 USA
[6] Univ Calgary, Oncol Biochem & Mol Biol, Calgary, AB, Canada
来源：
EUROPEAN JOURNAL OF CANCER | 2015年 / 51卷
关键词：
D O I：
10.1016/S0959-8049(16)30198-8
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
334
引用
收藏
页码：S65 / S65
页数：1
相关论文
共 50 条
  • [31] Outcomes and prognostic factors in patients with locally advanced cervical cancer treated with concurrent chemoradiotherapy
    Liu, Jing
    Tang, Guyu
    Zhou, Qin
    Kuang, Weilu
    RADIATION ONCOLOGY, 2022, 17 (01)
  • [32] PD-L1 expression and outcome of advanced melanoma patients treated with anti-PD-1/PD-L1 agents: a meta-analysis
    Abdel-Rahman, Omar
    IMMUNOTHERAPY, 2016, 8 (09) : 1081 - 1090
  • [33] Overall survival and PD-L1 expression in patients with recurrent or metastatic head and neck cancer treated with nivolumab
    Okamoto, Isaku
    Sato, Hiroki
    Tsukahara, Kiyoaki
    AURIS NASUS LARYNX, 2020, 47 (04) : 676 - 686
  • [34] Late recurrence of locally advanced cervical cancer treated with concurrent chemoradiotherapy
    Janmunee, Narumon
    Tangkananan, Aimwarin
    Thongkhao, Pitchaya
    Hanprasertpong, Jitti
    ONCOLOGY IN CLINICAL PRACTICE, 2022, 18 (06): : 393 - 401
  • [35] Neoadjuvant Chemoradiotherapy Enhances Tumor PD-L1 Expression in Pancreatic Cancer
    Den, Kanechika
    Murakami, Takashi
    Matsuyama, Ryusei
    Miyake, Kentaro
    Homma, Yuki
    Yabushita, Yasuhiro
    Mori, Ryutaro
    Hiroshima, Yukihiko
    Kato, Ikuma
    Endo, Itaru
    ANTICANCER RESEARCH, 2025, 45 (04) : 1731 - 1747
  • [36] Upregulation of tumor PD-L1 by neoadjuvant chemoradiotherapy (neoCRT) confers improved survival in patients with lymph node metastasis of locally advanced rectal cancers
    Chiang, Shu-Fen
    Huang, Chih-Yang
    Ke, Tao-Wei
    Chen, Tsung-Wei
    Lan, Yu-Ching
    You, Ying-Shu
    Chen, William Tzu-Liang
    Chao, K. S. Clifford
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2019, 68 (02) : 283 - 296
  • [37] Upregulation of tumor PD-L1 by neoadjuvant chemoradiotherapy (neoCRT) confers improved survival in patients with lymph node metastasis of locally advanced rectal cancers
    Shu-Fen Chiang
    Chih-Yang Huang
    Tao-Wei Ke
    Tsung-Wei Chen
    Yu-Ching Lan
    Ying-Shu You
    William Tzu-Liang Chen
    K. S. Clifford Chao
    Cancer Immunology, Immunotherapy, 2019, 68 : 283 - 296
  • [38] PD-L1 expression and survival among melanoma patients treated with standard immunotherapy or chemotherapy
    Steiniche, T.
    Danielsen, A. Vestergaard
    Wang, Z.
    Feng, Y.
    Nielsen, P. Switten
    Bastholt, L.
    Schmidt, H.
    Svane, I. M.
    Dolled-Filhart, M.
    Emancipator, K.
    Weiner, R.
    Busch-Sorensen, M.
    Zhou, W.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2017, 31 (07) : E319 - E321
  • [39] Prognostic value of tumor microenvironment based on PD-L1 expression and CD8+TILs density in locally advanced NSCLC treated with concurrent chemoradiotherapy
    Kaesmann, Lukas
    Gennen, Kathrin
    Taugner, Julian
    Eze, Chukwuka
    Karin, Monika
    Roengvoraphoj, Olarn
    Neumann, Jens
    Tufman, Amanda
    Orth, Michael
    Reu, Simone
    Belka, Claus
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2019, 7
  • [40] Deciphering The Tumor Immune Microenvironment Based on CD8+TiL Density and PD-L1 Expression in Locally Advanced NSCLC Treated with Concurrent Chemoradiotherapy
    Kaesmann, Lukas
    Gennen, Kathrin
    Taugner, Julian
    Eze, Chukwuka
    Roengvoraphoj, Olam
    Neumann, Jens
    Tufman, Amanda
    Orth, Michael
    Reu, Simone
    Belka, Claus
    Manapov, Farkhad
    ONCOLOGY RESEARCH AND TREATMENT, 2020, 43 : 119 - 119
12345